Clinical and Immunological Factors Associated with Postpartum Hepatic Flares in Immune-Tolerant Pregnant Women with Hepatitis B Virus Infection Treated with Telbivudine
Author:
Affiliation:
1. First Department of Liver Disease, Beijing Youan Hospital, Capital Medical University, Beijing, China
2. Department of Obstetrics and Gynecology, Beijing Youan Hospital, Capital Medical University, Beijing, China
Funder
China’s 13th 5-year plan for Key Projects in Infectious Diseases
Qinghai Province
Publisher
The Editorial Office of Gut and Liver
Subject
Gastroenterology,Hepatology
Link
http://pdf.medrang.co.kr/GNL/2021/015/GNL015-06-887.pdf
Reference29 articles.
1. Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: Results from China GAVI project final evaluation
2. Perinatal transmission of hepatitis B virus: an Australian experience
3. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study
4. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers
5. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real‐life practice
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Maternal-to-Child Transmission of Hepatitis B Virus and Hepatitis Delta Virus;Clinics in Liver Disease;2023-11
2. Enhancing interventions for prevention of mother-to-child- transmission of hepatitis B virus;JHEP Reports;2023-08
3. Postpartum hepatitis and host immunity in pregnant women with chronic HBV infection;Frontiers in Immunology;2023-01-04
4. Prevalence of hepatitis B virus infection among pregnant women in the mountainous regions of southern China: A retrospective single‐center study;Journal of Clinical Laboratory Analysis;2023-01
5. Clinical Features and T Cell Immune Characteristics of Postpartum Hepatitis Flare in Pregnant Women With HBeAg-Positive Chronic HBV Infection;Frontiers in Immunology;2022-04-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3